These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11298591)

  • 1. Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.
    Scrivener S; Kaminski ER; Demaine A; Prentice AG
    Br J Haematol; 2001 Mar; 112(4):959-64. PubMed ID: 11298591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
    Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
    Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen.
    Ampel NM; Christian L
    Med Mycol; 2000 Apr; 38(2):127-32. PubMed ID: 10817229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia.
    Frydecka I; Kosmaczewska A; Bocko D; Ciszak L; Wolowiec D; Kuliczkowski K; Kochanowska I
    Br J Cancer; 2004 May; 90(10):2042-8. PubMed ID: 15138491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
    Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
    Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface expression of CD25, CD54, and CD95 on B- and T-cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical course.
    Hjalmar V; Hast R; Kimby E
    Eur J Haematol; 2002 Mar; 68(3):127-34. PubMed ID: 12068792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
    Scrivener S; Goddard RV; Kaminski ER; Prentice AG
    Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.
    Dieckmann D; Plottner H; Berchtold S; Berger T; Schuler G
    J Exp Med; 2001 Jun; 193(11):1303-10. PubMed ID: 11390437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
    Lombardi VR; García M; Rey L; Cacabelos R
    J Neuroimmunol; 1999 Jun; 97(1-2):163-71. PubMed ID: 10408971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage.
    Mozaffari F; Hansson L; Kiaii S; Ju X; Rossmann ED; Rabbani H; Mellstedt H; Osterborg A
    Br J Haematol; 2004 Feb; 124(3):315-24. PubMed ID: 14717778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo.
    Metzler B; Burkhart C; Wraith DC
    Int Immunol; 1999 May; 11(5):667-75. PubMed ID: 10330272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.
    Levings MK; Sangregorio R; Roncarolo MG
    J Exp Med; 2001 Jun; 193(11):1295-302. PubMed ID: 11390436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention.
    Leng Q; Bentwich Z; Magen E; Kalinkovich A; Borkow G
    AIDS; 2002 Mar; 16(4):519-29. PubMed ID: 11872994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia.
    Motta M; Rassenti L; Shelvin BJ; Lerner S; Kipps TJ; Keating MJ; Wierda WG
    Leukemia; 2005 Oct; 19(10):1788-93. PubMed ID: 16094420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25high regulatory cells in human peripheral blood.
    Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
    J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.